Human Reproduction, Vol. 14, No. 7, 1744-1748,
July 1999
© 1999 European Society of Human Reproduction and Embryology
A rational approach to the management of low responders in in-vitro fertilization: Opinion
Center for Human Reproduction Illinois, and the Department of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago, Illinois, USA
| Introduction |
|---|
Low ovarian response to stimulation occurs in ~924% of patients (Keay et al., 1997
This paper will briefly review the various stimulation protocols (successful and unsuccessful) that have been attempted to improve IVF results in low responders. Included is our experience with a protocol that has met with some success. We would also like to propose a strategy where one
| Notes |
|---|
| References |
|---|
This article has been cited by other articles:
![]() |
J. Balasch, F. Fabregues, J. Penarrubia, F. Carmona, R. Casamitjana, M. Creus, D. Manau, G. Casals, and J. A. Vanrell Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH Hum. Reprod., July 1, 2006; 21(7): 1884 - 1893. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kan, E. H. Y. Ng, W. S. B. Yeung, and P. C. Ho Perifollicular vascularity in poor ovarian responders during IVF Hum. Reprod., June 1, 2006; 21(6): 1539 - 1544. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Penarrubia, F. Fabregues, D. Manau, M. Creus, G. Casals, R. Casamitjana, F. Carmona, J. A. Vanrell, and J. Balasch Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment Hum. Reprod., April 1, 2005; 20(4): 915 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Penarrubia, F. Fabregues, D. Manau, M. Creus, F. Carmona, R. Casamitjana, J. A. Vanrell, and J. Balasch Previous cycle cancellation due to poor follicular development as a predictor of ovarian response in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment Hum. Reprod., March 1, 2005; 20(3): 622 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kailasam, S.D. Keay, P. Wilson, W.C.L. Ford, and J.M. Jenkins Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome Hum. Reprod., July 1, 2004; 19(7): 1544 - 1547. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.D. Keay, N.H. Liversedge, V.A. Akande, R.S. Mathur, and J.M. Jenkins Serum IGF-1 concentrations following pituitary desensitization do not predict the ovarian response to gonadotrophin stimulation prior to IVF Hum. Reprod., September 1, 2003; 18(9): 1797 - 1801. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nikolaou, S. Lavery, C. Turner, R. Margara, and G. Trew Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure? Hum. Reprod., April 1, 2002; 17(4): 1106 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.M. Ranieri, P. Phophong, I. Khadum, F. Meo, C. Davis, and P. Serhal Simultaneous evaluation of basal FSH and oestradiol response to GnRH analogue (F-G-test) allows effective drug regimen selection for IVF Hum. Reprod., April 1, 2001; 16(4): 673 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Garcia-Velasco, V. Isaza, A. Requena, Fco.J. Martinez-Salazar, A. Landazabal, J. Remohi, A. Pellicer, and C. Simon High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial Hum. Reprod., November 1, 2000; 15(11): 2292 - 2296. [Abstract] [Full Text] [PDF] |
||||
